What do you wish you’d invented?
Nitro infused beers. Trust me, the taste is unbelievable!
What trend do you see shaping the industry?
Patient centricity are the big buzzwords of the moment, but it has been tricky for companies to turn that into meaningful action.
One way to think about patient centricity is to think about how to get the voice of the patient into medicine development. So, how do you best engage with patients to get that voice?
The three key areas to think about are:
1) Patient insights – what do patients need and want?
2) Patient collaboration – how do we integrate patient inputs into medicine development?
3) Patient activation and enablement – how do we support the patient community and lower barriers to enable participation?
What has made you proud in your career?
I’ve been fortunate to have been part of or led more than 50 advisory engagements for over 15 different clients in the 11 years I’ve been at Kinapse.
In all those projects, I’m proud that I’ve always ‘consulted with clients’, rather than ‘consulted to clients’. I’m a firm believer that collaboration is the key ingredient in helping create the best possible solution and the best possible chance of successful implementation.
Where were you before?
Before Kinapse, I worked in bench research, looking at novel approaches and possible drug targets for schizophrenia, anxiety and obsessive compulsive disorder.
I also worked for a year in medical communications. I shot productions for campaigns around disease awareness and patient uses of medication.
Why did you choose to work in the life sciences industry?
I believe medicines can radically improving population health at scale. Getting that right is complicated; it involves carefully orchestrating different objectives, disciplines and people.
It’s a privilege to be a part of that process, helping companies whose mission it is to make these medicines. We make it possible for them to make more effective medicines faster.